1.45 USD
↗ 0.01 (0.69%)AT CLOSE (03:59 PM EDT)
Lipocine Inc.
LPCNNASDAQ • USD
1.43
↘ 0.02 (1.72%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.43
↘ 0.02 (1.72%)
Market: CLOSED
LPCN is currently priced at $1.44. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place LPCN at a fair price relative to peers.
Technical & fundamental data as of Oct 26, 2026.
Open?$1.44
High?$1.45
Low?$1.40
Prev. Close?$1.44
Volume?108.9K
Avg. Volume?3.8M
VWAP?$1.43
Rel. Volume?0.03x
Bid / Ask
Bid?$1.23 × 100
Ask?$1.66 × 100
Spread?$0.43
Midpoint?$1.44
Valuation & Ratios
Market Cap?11.9M
Shares Out?8.2M
Float?7.6M
Float %?92.7%
P/E Ratio?N/A
P/B Ratio?0.55
EPS?-$1.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
Employees
14
Market Cap
11.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-06-05
Address
675 ARAPEEN DRIVE, SUITE 202
SALT LAKE CITY, X1 84108
Phone: 801 994 7383
SALT LAKE CITY, X1 84108
Phone: 801 994 7383
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?51
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.86Distress
Confidence?54%Low
Short InterestLow
Short % of Float?4.60%Low
Short Interest?351.4K
Days to Cover?1.0
Free Float7.6M
Avg Daily Volume9.6M
Settlement Date2026-10-15
Financial Health
Current Ratio?11.48Strong
Quick Ratio?11.48Strong
Cash Ratio?2.41Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score75/100
P/E?N/A▾
P/B?0.55CHEAP▾
Peers100
S&P97
P/S?9.42HIGH▾
Peers100
S&P9
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?5.47FAIR▾
Peers100
S&P32
Returns & Efficiency
ROE?-54.4%WEAK▾
S&P3
ROA?-49.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-11190794
Enterprise Value?$6.9M
Fundamentals ratios updated end of day